VEGFA and ischemia: This is of therapeutic interest because ratios of VEGF or PlGF to sR1 levels in plasma are increasingly of interest as a biomarker (e.g. in pre-eclampsia) [70], and sR1 levels increase in diabetic mice following hindlimb ischemia [88].